EWM
ABBV icon

Evolution Wealth Management’s AbbVie ABBV Stock Holding History

Evolution Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$185K Buy
735
+74
+11% +$15.9K 0.11% 129
2026
Q1 		$144K Buy
661
+49
+8% +$10.9K 0.11% 140
2025
Q4 		$140K Buy
612
+511
+506% +$116K 0.12% 138
2025
Q3 		$23.4K Sell
101
-39
-28% -$7.94K 0.02% 279
2025
Q2 		$26K Buy
+140
New +$26K 0.03% 249

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Evolution Wealth Management's ABBV Position: Q2 2026 in Review

Evolution Wealth Management increased its AbbVie (ABBV) stake by 11% in Q2 2026, buying an estimated $15.9K and bringing the position to 735 shares worth $185K. The position accounts for 0.11% of the portfolio, ranked #129.

Evolution Wealth Management first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Evolution Wealth Management held 735 shares of AbbVie worth $185K as of Q2 2026.
  • Evolution Wealth Management bought 74 AbbVie shares in Q2 2026, an estimated $15.9K.
  • AbbVie made up 0.11% of Evolution Wealth Management's portfolio in Q2 2026, its #129 holding.
  • Evolution Wealth Management first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Evolution Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.